PATIENT PRODUCT INFORMATION - HOW TO WRIT E THE LEAFLETS

The main accusation against package inserts is that they are not under stood by the patients : the vocabulary used is uncommon and the inform ation is not always relevant A recent European directive on package in serts for drugs concerning human use specifies the items that must be mentioned. Following this directive and regarding patient interest, a presentation for notices is proposed in which the subject headings are presented as questions and the text is a guide to drug practical use to provide the elements of surveillance. A summarized version added to this detailed notice for the convenience of the patient is also propo sed, which should be translated into the language of each European Com munity's member state.